IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), a developer of medical image processing platforms, said the University of Texas MD Anderson Cancer Center has become a customer.
It is the latest brain cancer centre to purchase an annual subscription of IB Clinic software, an automated processing application that generates quantitative magnetic resonance (MR) perfusion images and other maps useful in assessing brain tumours and monitoring treatment.
The purchase also includes IB Clinic - Mac edition, which comprises all IB modules as plugins to the OsiriX DICOM (digital information and communications in medicine) environment.
IB Clinic is a product of Imaging Biometrics, a subsidiary of IQ-AI.
"The automated processing is ideal for high-volume centres such as this, and the quantitative capability allows direct comparison of longitudinal scans, no matter where or when the patient is scanned," said Trevor Brown, the chief executive officer of IQ-AI.
Shares in IQ-AI were up 8% at 6.75p following the news.